Role of metabolism in the immunobiology of regulatory T cells

Journal of Immunology

Volumn 197, Issue 7, 2016, Pages 2567-2575

  Galgani, Mario ^a   De Rosa, Veronica ^a,b   Cava, Antonio La ^c   Matarese, Giuseppe ^d  

^a CNR   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; 5' NUCLEOTIDASE; ADIPOCYTOKINE; ADIPOCYTOKINE RECEPTOR; ADIPONECTIN; AROMATIC HYDROCARBON RECEPTOR; B7 ANTIGEN; CARNITINE PALMITOYLTRANSFERASE I; CD28 ANTIGEN; CD39 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; LEPTIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PURINERGIC P2X RECEPTOR; PYRUVATE DEHYDROGENASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; FORKHEAD TRANSCRIPTION FACTOR;

AUTOIMMUNITY; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CYTOKINE PRODUCTION; HUMAN; IMMUNOBIOLOGY; LYMPHOCYTE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 84989902499     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600242     Document Type: Review

References (121)

1. Wing, K., and S. Sakaguchi. 2010. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11: 7-13.
2. Luo, C. T., and M. O. Li. 2013. Transcriptional control of regulatory T cell development and function. Trends Immunol. 34: 531-539.
3. Painter, M. W., S. Davis, R. R. Hardy, D. Mathis, and C. Benoist, The Immunological Genome Project Consortium. 2011. Transcriptomes of the B and T lineages compared by multiplatform microarray profiling. J. Immunol. 186: 3047- 3057.
4. Procaccini, C., F. Carbone, D. Di Silvestre, F. Brambilla, V. De Rosa, M. Galgani, D. Faicchia, G. Marone, D. Tramontano, M. Corona, et al. 2016. The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements. [Published erratum appears in 2016 Immunity 44: 712.] Immunity 44: 406-421.
5. Michalek, R. D., V. A. Gerriets, S. R. Jacobs, A. N. Macintyre, N. J. MacIver, E. F. Mason, S. A. Sullivan, A. G. Nichols, and J. C. Rathmell. 2011. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186: 3299-3303.
6. Macintyre, A. N., V. A. Gerriets, A. G. Nichols, R. D. Michalek, M. C. Rudolph, D. Deoliveira, S. M. Anderson, E. D. Abel, B. J. Chen, L. P. Hale, and J. C. Rathmell. 2014. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20: 61-72.
7. Procaccini, C., V. De Rosa, M. Galgani, L. Abanni, G. Calì, A. Porcellini, F. Carbone, S. Fontana, T. L. Horvath, A. La Cava, and G. Matarese. 2010. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33: 929-941.
8. Zeng, H., K. Yang, C. Cloer, G. Neale, P. Vogel, and H. Chi. 2013. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499: 485-490.
9. Vukmanovic-Stejic, M., E. Agius, N. Booth, P. J. Dunne, K. E. Lacy, J. R. Reed, T. O. Sobande, S. Kissane, M. Salmon, M. H. Rustin, and A. N. Akbar. 2008. The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J. Clin. Invest. 118: 3639-3650.
10. Powell, J. D., and G. M. Delgoffe. 2010. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 33: 301-311.
11. Zheng, Y., S. L. Collins, M. A. Lutz, A. N. Allen, T. P. Kole, P. E. Zarek, and J. D. Powell. 2007. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J. Immunol. 178: 2163-2170.
12. Kang, J., S. J. Huddleston, J. M. Fraser, and A. Khoruts. 2008. De novo induction of antigen-specific CD4+CD25+FOXP3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J. Leukoc. Biol. 83: 1230-1239.
13. Delgoffe, G. M., T. P. Kole, Y. Zheng, P. E. Zarek, K. L. Matthews, B. Xiao, P. F. Worley, S. C. Kozma, and J. D. Powell. 2009. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30: 832-844.
14. Wang, R., C. P. Dillon, L. Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L. L. McCormick, P. Fitzgerald, H. Chi, J. Munger, and D. R. Green. 2011. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35: 871-882.
15. Gerriets, V. A., R. J. Kishton, A. G. Nichols, A. N. Macintyre, M. Inoue, O. Ilkayeva, P. S. Winter, X. Liu, B. Priyadharshini, M. E. Slawinska, et al. 2015. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125: 194-207.
16. Thorens, B., and M. Mueckler. 2010. Glucose transporters in the 21st century. Am. J. Physiol. Endocrinol. Metab. 298: E141-E145.
17. Porstmann, T., C. R. Santos, B. Griffiths, M. Cully, M. Wu, S. Leevers, J. R. Griffiths, Y. L. Chung, and A. Schulze. 2008. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8: 224-236.
18. Berod, L., C. Friedrich, A. Nandan, J. Freitag, S. Hagemann, K. Harmrolfs, A. Sandouk, C. Hesse, C. N. Castro, H. Bähre, et al. 2014. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20: 1327-1333.
19. Wang, B. T., G. S. Ducker, A. J. Barczak, R. Barbeau, D. J. Erle, and K. M. Shokat. 2011. The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile. Proc. Natl. Acad. Sci. USA 108: 15201-15206.
20. De Rosa, V., C. Procaccini, G. Calì, G. Pirozzi, S. Fontana, S. Zappacosta, A. La Cava, and G. Matarese. 2007. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241-255.
21. Huynh, A., M. DuPage, B. Priyadharshini, P. T. Sage, J. Quiros, C. M. Borges, N. Townamchai, V. A. Gerriets, J. C. Rathmell, A. H. Sharpe, et al. 2015. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16: 188-196.
22. Shrestha, S., K. Yang, C. Guy, P. Vogel, G. Neale, and H. Chi. 2015. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat. Immunol. 16: 178-187.
23. Wei, J., L. Long, K. Yang, C. Guy, S. Shrestha, Z. Chen, C. Wu, P. Vogel, G. Neale, D. R. Green, and H. Chi. 2016. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat. Immunol. 17: 277-285.
24. Kaelin Jr., W. G. 2005. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem. Biophys. Res. Commun. 338: 627-638.
25. Shi, L. Z., R. Wang, G. Huang, P. Vogel, G. Neale, D. R. Green, and H. Chi. 2011. HIF1a-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208: 1367-1376.
26. Wang, G. L., B. H. Jiang, E. A. Rue, and G. L. Semenza. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92: 5510-5514.
27. Semenza, G. L. 2011. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb. Symp. Quant. Biol. 76: 347-353.
28. Iyer, N. V., L. E. Kotch, F. Agani, S. W. Leung, E. Laughner, R. H. Wenger, M. Gassmann, J. D. Gearhart, A. M. Lawler, A. Y. Yu, and G. L. Semenza. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 a. Genes Dev. 12: 149-162.
29. Kim, J. W., I. Tchernyshyov, G. L. Semenza, and C. V. Dang. 2006. HIF-1- mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3: 177-185.
30. Papandreou, I., R. A. Cairns, L. Fontana, A. L. Lim, and N. C. Denko. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3: 187-197.
31. Sun, Q., X. Chen, J. Ma, H. Peng, F. Wang, X. Zha, Y. Wang, Y. Jing, H. Yang, R. Chen, et al. 2011. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc. Natl. Acad. Sci. USA 108: 4129-4134.
32. Clambey, E. T., E. N. McNamee, J. A. Westrich, L. E. Glover, E. L. Campbell, P. Jedlicka, E. F. de Zoeten, J. C. Cambier, K. R. Stenmark, S. P. Colgan, and H. K. Eltzschig. 2012. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl. Acad. Sci. USA 109: E2784-E2793.
33. Beier, U. H., A. Angelin, T. Akimova, L. Wang, Y. Liu, H. Xiao, M. A. Koike, S. A. Hancock, T. R. Bhatti, R. Han, et al. 2015. Essential role of mitochondrial energy metabolism in Foxp3? T-regulatory cell function and allograft survival. FASEB J. 29: 2315-2326.
34. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
35. Sauer, S., L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z. A. Knight, B. S. Cobb, D. Cantrell, E. O'Connor, et al. 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105: 7797-7802.
36. Barron, L., H. Dooms, K. K. Hoyer, W. Kuswanto, J. Hofmann, W. E. O'Gorman, and A. K. Abbas. 2010. Cutting edge: mechanisms of IL-2- dependent maintenance of functional regulatory T cells. J. Immunol. 185: 6426- 6430.
37. Eleftheriadis, T., G. Pissas, A. Karioti, G. Antoniadi, N. Antoniadis, V. Liakopoulos, and I. Stefanidis. 2013. Dichloroacetate at therapeutic concentration alters glucose metabolism and induces regulatory T-cell differentiation in alloreactive human lymphocytes. J. Basic Clin. Physiol. Pharmacol. 24: 271-276.
38. De Rosa, V., M. Galgani, A. Porcellini, A. Colamatteo, M. Santopaolo, C. Zuchegna, A. Romano, S. De Simone, C. Procaccini, C. La Rocca, et al. 2015. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat. Immunol. 16: 1174-1184.
39. Dang, E. V., J. Barbi, H. Y. Yang, D. Jinasena, H. Yu, Y. Zheng, Z. Bordman, J. Fu, Y. Kim, H. R. Yen, et al. 2011. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146: 772-784.
40. Battaglia, M., A. Stabilini, and M. G. Roncarolo. 2005. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105: 4743-4748.
41. Valmori, D., V. Tosello, N. E. Souleimanian, E. Godefroy, L. Scotto, Y. Wang, and M. Ayyoub. 2006. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J. Immunol. 177: 944-949.
42. Oh, B., J. Yoon, A. Farris, A. Kirk, S. Knechtle, and J. Kwun. 2016. Rapamycin interferes post-depletion regulatory T cell homeostasis and enhances DSA formation corrected by CTLA4-Ig. Am. J. Transplant. DOI:10.1111/ajt.13789.
43. Wang, Y., G. Camirand, Y. Lin, M. Froicu, S. Deng, W. D. Shlomchik, F. G. Lakkis, and D. M. Rothstein. 2011. Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice. J. Immunol. 186: 2809-2818.
44. Sabbatini, M., G. Ruggiero, A. T. Palatucci, V. Rubino, S. Federico, A. Giovazzino, L. Apicella, M. Santopaolo, G. Matarese, M. Galgani, and G. Terrazzano. 2015. Oscillatory mTOR inhibition and Treg increase in kidney transplantation. Clin. Exp. Immunol. 182: 230-240.
45. Allan, S. E., L. Passerini, R. Bacchetta, N. Crellin, M. Dai, P. C. Orban, S. F. Ziegler, M. G. Roncarolo, and M. K. Levings. 2005. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 115: 3276-3284.
46. Kaur, G., J. C. Goodall, L. B. Jarvis, and J. S. Hill Gaston. 2010. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells-identification of Foxp3D7 in human regulatory T cells. Mol. Immunol. 48: 321-332.
47. Joly, A. L., S. Liu, C. I. Dahlberg, R. K. Mailer, L. S. Westerberg, and J. Andersson. 2015. Foxp3 lacking exons 2 and 7 is unable to confer suppressive ability to regulatory T cells in vivo. J. Autoimmun. 63: 23-30.
48. Mailer, R. K., A. L. Joly, S. Liu, S. Elias, J. Tegner, and J. Andersson. 2015. IL-1b promotes Th17 differentiation by inducing alternative splicing of FOXP3. Sci. Rep. 5: 14674.
49. van Loosdregt, J., Y. Vercoulen, T. Guichelaar, Y. Y. Gent, J. M. Beekman, O. van Beekum, A. B. Brenkman, D. J. Hijnen, T. Mutis, E. Kalkhoven, et al. 2010. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115: 965-974.
50. Michalek, R. D., V. A. Gerriets, A. G. Nichols, M. Inoue, D. Kazmin, C. Y. Chang, M. A. Dwyer, E. R. Nelson, K. N. Pollizzi, O. Ilkayeva, et al. 2011. Estrogen-related receptor-A is a metabolic regulator of effector T-cell activation and differentiation. Proc. Natl. Acad. Sci. USA 108: 18348-18353.
51. Gottschalk, R. A., E. Corse, and J. P. Allison. 2010. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207: 1701- 1711.
52. Miskov-Zivanov, N., M. S. Turner, L. P. Kane, P. A. Morel, and J. R. Faeder. 2013. The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Sci. Signal. 6: ra97.
53. Li, M. O., and A. Y. Rudensky. 2016. T cell receptor signalling in the control of regulatory T cell differentiation and function. Nat. Rev. Immunol. 16: 220-233.
54. Hoeppli, R. E., D. Wu, L. Cook, and M. K. Levings. 2015. The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome. Front. Immunol. 6: 61.
55. Schenk, U., M. Frascoli, M. Proietti, R. Geffers, E. Traggiai, J. Buer, C. Ricordi, A. M. Westendorf, and F. Grassi. 2011. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci. Signal. 4: ra12.
56. Sitkovsky, M., D. Lukashev, S. Deaglio, K. Dwyer, S. C. Robson, and A. Ohta. 2008. Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br. J. Pharmacol. 153(Suppl. 1): S457-S464.
57. Borsellino, G., M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Höpner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232.
58. Mandapathil, M., B. Hilldorfer, M. J. Szczepanski, M. Czystowska, M. Szajnik, J. Ren, S. Lang, E. K. Jackson, E. Gorelik, and T. L. Whiteside. 2010. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J. Biol. Chem. 285: 7176-7186.
59. Ohta, A., R. Kini, A. Ohta, M. Subramanian, M. Madasu, and M. Sitkovsky. 2012. The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. Front. Immunol. 3: 190.
60. Raverdeau, M., and K. H. Mills. 2014. Modulation of T cell and innate immune responses by retinoic Acid. J. Immunol. 192: 2953-2958.
61. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-b and retinoic aciddependent mechanism. J. Exp. Med. 204: 1757-1764.
62. Jaensson, E., H. Uronen-Hansson, O. Pabst, B. Eksteen, J. Tian, J. L. Coombes, P. L. Berg, T. Davidsson, F. Powrie, B. Johansson-Lindbom, and W. W. Agace. 2008. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J. Exp. Med. 205: 2139-2149.
63. Lu, L., Q. Lan, Z. Li, X. Zhou, J. Gu, Q. Li, J. Wang, M. Chen, Y. Liu, Y. Shen, et al. 2014. Critical role of all-Trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc. Natl. Acad. Sci. USA 111: E3432-E3440.
64. Urry, Z., E. S. Chambers, E. Xystrakis, S. Dimeloe, D. F. Richards, L. Gabrysová, J. Christensen, A. Gupta, S. Saglani, A. Bush, et al. 2012. The role of 1a, 25- dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL- 10+ CD4+ T cells. Eur. J. Immunol. 42: 2697-2708.
65. Chambers, E. S., D. Suwannasaen, E. H. Mann, Z. Urry, D. F. Richards, G. Lertmemongkolchai, and C. M. Hawrylowicz. 2014. 1a, 25-dihydroxyvitamin D3 in combination with transforming growth factor-b increases the frequency of Foxp3? regulatory T cells through preferential expansion and usage of interleukin- 2. Immunology 143: 52-60.
66. Klysz, D., X. Tai, P. A. Robert, M. Craveiro, G. Cretenet, L. Oburoglu, C. Mongellaz, S. Floess, V. Fritz, M. I. Matias, et al. 2015. Glutamine-dependent a-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Sci. Signal. 8: ra97.
67. Song, E. K., J. M. Yim, J. Y. Yim, M. Y. Song, H. W. Rho, S. K. Yim, Y. H. Han, S. Y. Jeon, H. S. Kim, H. Y. Yhim, et al. 2013. Glutamine protects mice from acute graft-versus-host disease (aGVHD). Biochem. Biophys. Res. Commun. 435: 94-99.
68. Baban, B., P. R. Chandler, M. D. Sharma, J. Pihkala, P. A. Koni, D. H. Munn, and A. L. Mellor. 2009. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J. Immunol. 183: 2475-2483.
69. Yan, Y., G. X. Zhang, B. Gran, F. Fallarino, S. Yu, H. Li, M. L. Cullimore, A. Rostami, and H. Xu. 2010. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J. Immunol. 185: 5953-5961.
70. Curran, T. A., R. B. Jalili, A. Farrokhi, and A. Ghahary. 2014. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells. Immunobiology 219: 17-24.
71. Rouse, M., N. P. Singh, P. S. Nagarkatti, and M. Nagarkatti. 2013. Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells. Br. J. Pharmacol. 169: 1305-1321.
72. Cobbold, S. P., E. Adams, C. A. Farquhar, K. F. Nolan, D. Howie, K. O. Lui, P. J. Fairchild, A. L. Mellor, D. Ron, and H. Waldmann. 2009. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. USA 106: 12055-12060.
73. Morse, M. A., A. Hobeika, D. Serra, K. Aird, M. McKinney, A. Aldrich, T. Clay, D. Mourich, H. K. Lyerly, P. L. Iversen, and G. R. Devi. 2012. Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function. Cancer Gene Ther. 19: 30-37.
74. Cipolletta, D., M. Feuerer, A. Li, N. Kamei, J. Lee, S. E. Shoelson, C. Benoist, and D. Mathis. 2012. PPAR-g is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486: 549-553.
75. Feuerer, M., L. Herrero, D. Cipolletta, A. Naaz, J. Wong, A. Nayer, J. Lee, A. B. Goldfine, C. Benoist, S. Shoelson, and D. Mathis. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15: 930-939.
76. Lord, G. M., G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901.
77. Matarese, G., A. Di Giacomo, V. Sanna, G. M. Lord, J. K. Howard, A. Di Tuoro, S. R. Bloom, R. I. Lechler, S. Zappacosta, and S. Fontana. 2001. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 166: 5909-5916.
78. Liu, Y., Y. Yu, G. Matarese, and A. La Cava. 2012. Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. J. Immunol. 188: 2070-2073.
79. Tsang, J. Y., D. Li, D. Ho, J. Peng, A. Xu, J. Lamb, Y. Chen, and P. K. Tam. 2011. Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int. Immunopharmacol. 11: 604-609.
80. Piccio, L., C. Cantoni, J. G. Henderson, D. Hawiger, M. Ramsbottom, R. Mikesell, J. Ryu, C. S. Hsieh, V. Cremasco, W. Haynes, et al. 2013. Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. Eur. J. Immunol. 43: 2089-2100.
81. Ramos-Ramírez, P., C. Malmhäll, K. Johansson, J. Lötvall, and A. Bossios. 2016. Weight gain alters adiponectin receptor 1 expression on adipose tissue-resident Helios+ regulatory T cells. Scand. J. Immunol. 83: 244-254.
82. Arpaia, N., C. Campbell, X. Fan, S. Dikiy, J. van der Veeken, P. deRoos, H. Liu, J. R. Cross, K. Pfeffer, P. J. Coffer, and A. Y. Rudensky. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451-455.
83. Smith, P. M., M. R. Howitt, N. Panikov, M. Michaud, C. A. Gallini, M. Bohlooly-Y, J. N. Glickman, and W. S. Garrett. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341: 569-573.
84. Round, J. L., and S. K. Mazmanian. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107: 12204-12209.
85. Furusawa, Y., Y. Obata, S. Fukuda, T. A. Endo, G. Nakato, D. Takahashi, Y. Nakanishi, C. Uetake, K. Kato, T. Kato, et al. 2014. Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells. [Published erratum appears in 2013 Nature 504: 446.] Nature 506: 254.
86. Round, J. L., S. M. Lee, J. Li, G. Tran, B. Jabri, T. A. Chatila, and S. K. Mazmanian. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332: 974-977.
87. Atarashi, K., T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, Y. Momose, G. Cheng, S. Yamasaki, T. Saito, Y. Ohba, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341.
88. Atarashi, K., T. Tanoue, K. Oshima, W. Suda, Y. Nagano, H. Nishikawa, S. Fukuda, T. Saito, S. Narushima, K. Hase, et al. 2013. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232-236.
89. Carbone, F., V. De Rosa, P. B. Carrieri, S. Montella, D. Bruzzese, A. Porcellini, C. Procaccini, A. La Cava, and G. Matarese. 2014. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 20: 69-74.
90. Galgani, M., C. Procaccini, V. De Rosa, F. Carbone, P. Chieffi, A. La Cava, and G. Matarese. 2010. Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway. J. Immunol. 185: 7474-7479.
91. Sarbassov, D. D., S. M. Ali, S. Sengupta, J. H. Sheen, P. P. Hsu, A. F. Bagley, A. L. Markhard, and D. M. Sabatini. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22: 159-168.
92. Wan, X., B. Harkavy, N. Shen, P. Grohar, and L. J. Helman. 2007. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26: 1932-1940.
93. Choo, A. Y., S. O. Yoon, S. G. Kim, P. P. Roux, and J. Blenis. 2008. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-Type-specific repression of mRNA translation. Proc. Natl. Acad. Sci. USA 105: 17414-17419.
94. Park, Y., H. S. Jin, J. Lopez, C. Elly, G. Kim, M. Murai, M. Kronenberg, and Y. C. Liu. 2013. TSC1 regulates the balance between effector and regulatory T cells. J. Clin. Invest. 123: 5165-5178.
95. Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949.
96. Bates, G. J., S. B. Fox, C. Han, R. D. Leek, J. F. Garcia, A. L. Harris, and A. H. Banham. 2006. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 24: 5373-5380.
97. Barbi, J., D. Pardoll, and F. Pan. 2014. Treg functional stability and its responsiveness to the microenvironment. Immunol. Rev. 259: 115-139.
98. Opitz, C. A., U. M. Litzenburger, F. Sahm, M. Ott, I. Tritschler, S. Trump, T. Schumacher, L. Jestaedt, D. Schrenk, M. Weller, et al. 2011. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478: 197-203.
99. Nguyen, N. T., A. Kimura, T. Nakahama, I. Chinen, K. Masuda, K. Nohara, Y. Fujii-Kuriyama, and T. Kishimoto. 2010. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl. Acad. Sci. USA 107: 19961-19966.
100. Hou, D. Y., A. J. Muller, M. D. Sharma, J. DuHadaway, T. Banerjee, M. Johnson, A. L. Mellor, G. C. Prendergast, and D. H. Munn. 2007. Inhibition of indoleamine 2, 3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-Tryptophan correlates with antitumor responses. Cancer Res. 67: 792-801.
101. Sharma, M. D., R. Shinde, T. L. McGaha, L. Huang, R. B. Holmgaard, J. D. Wolchok, M. R. Mautino, E. Celis, A. H. Sharpe, L. M. Francisco, et al. 2015. The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment. Sci. Adv. 1: e1500845.
102. Munn, D. H., M. D. Sharma, B. Baban, H. P. Harding, Y. Zhang, D. Ron, and A. L. Mellor. 2005. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase. Immunity 22: 633- 642.
103. Fallarino, F., U. Grohmann, S. You, B. C. McGrath, D. R. Cavener, C. Vacca, C. Orabona, R. Bianchi, M. L. Belladonna, C. Volpi, et al. 2006. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor z-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176: 6752-6761.
104. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2, 3-dioxygenase. J. Clin. Invest. 117: 2570-2582.
105. Moretti, S., E. Menicali, P. Voce, S. Morelli, S. Cantarelli, M. Sponziello, R. Colella, F. Fallarino, C. Orabona, A. Alunno, et al. 2014. Indoleamine 2, 3- dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment. J. Clin. Endocrinol. Metab. 99: E832-E840.
106. Huang, S., S. Apasov, M. Koshiba, and M. Sitkovsky. 1997. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600-1610.
107. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
108. Makki, K., S. Taront, O. Molendi-Coste, E. Bouchaert, B. Neve, E. Eury, S. Lobbens, M. Labalette, H. Duez, B. Staels, et al. 2014. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice. PLoS One 9: e92684.
109. Battaglia, M., A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M. G. Roncarolo. 2006. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177: 8338-8347.
110. Monti, P., M. Scirpoli, P. Maffi, L. Piemonti, A. Secchi, E. Bonifacio, M. G. Roncarolo, and M. Battaglia. 2008. Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells. Diabetes 57: 2341-2347.
111. Battaglia, M., A. Stabilini, E. Draghici, B. Migliavacca, S. Gregori, E. Bonifacio, and M. G. Roncarolo. 2006. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55: 1571- 1580.
112. Esposito, M., F. Ruffini, M. Bellone, N. Gagliani, M. Battaglia, G. Martino, and R. Furlan. 2010. Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation. J. Neuroimmunol. 220: 52-63.
113. Lee, S. Y., S. H. Lee, E. J. Yang, E. K. Kim, J. K. Kim, D. Y. Shin, and M. L. Cho. 2015. Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the Th17/Treg balance. PLoS One 10: e0135858.
114. Negrotto, L., M. F. Farez, and J. Correale. 2016. Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurol. 73: 520-528.
115. Mazmanian, S. K., J. L. Round, and D. L. Kasper. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620-625.
116. Ochoa-Repáraz, J., D.W. Mielcarz, L. E. Ditrio, A. R. Burroughs, D. M. Foureau, S. Haque-Begum, and L. H. Kasper. 2009. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 183: 6041-6050.
117. Ochoa-Repáraz, J., D. W. Mielcarz, Y. Wang, S. Begum-Haque, S. Dasgupta, D. L. Kasper, and L. H. Kasper. 2010. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 3: 487-495.
118. Di Giacinto, C., M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-b-bearing regulatory cells. J. Immunol. 174: 3237- 3246.
119. Livingston, M., D. Loach, M. Wilson, G. W. Tannock, and M. Baird. 2010. Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response. Immunol. Cell Biol. 88: 99-102.
120. Galgani, M., R. Nugnes, D. Bruzzese, F. Perna, V. De Rosa, C. Procaccini, E. Mozzillo, C. M. Cilio, H. Elding Larsson, A. Lernmark, et al. 2013. Metaimmunological profiling of children with type 1 diabetes identifies new biomarkers to monitor disease progression. Diabetes 62: 2481-2491.
121. Munger, K. L., J. Bentzen, B. Laursen, E. Stenager, N. Koch-Henriksen, T. I. Sørensen, and J. L. Baker. 2013. Childhood body mass index and multiple sclerosis risk: A long-Term cohort study. Mult. Scler. 19: 1323-1329.